← back to search

Yi‐Hao Chan

Rockefeller University · US
🔎 Find collaborators in Infectious Diseases · Public Health, Environmental and Occupational Health →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Mosquito-borne diseases and control, and Long-Term Effects of COVID-19.
h-index
24
citations
3,139
works
62
NIH funding
primary concept
Medicine
email

Recent publications

Human LFA-1 governs T cell immune surveillance of the skin
Science Immunology 2026cited by 2position: middledoi
Human TMEFF1 is a restriction factor for herpes simplex virus in the brain
Nature 2024cited by 22position: firstdoi
SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency
The Journal of Experimental Medicine 2024cited by 20position: firstdoi
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya
EMBO Molecular Medicine 2024cited by 18position: middledoi
Human DBR1 deficiency impairs stress granule–dependent PKR antiviral immunity
The Journal of Experimental Medicine 2024cited by 12position: middledoi
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
Cell 2023cited by 109position: middledoi
Encephalitis and poor neuronal death–mediated control of herpes simplex virus in human inherited RIPK3 deficiency
Science Immunology 2023cited by 49position: middledoi
Encephalitis and poor neuronal death-mediated control of herpes simplex virus in human inherited RIPK3 deficiency
Clinical Immunology 2023cited by 3position: middledoi
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
Science 2022cited by 165position: middledoi
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Nature Communications 2022cited by 56position: middledoi
Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
EMBO Molecular Medicine 2022cited by 38position: middledoi
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
The Lancet Microbe 2021cited by 401position: middledoi
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
eLife 2021cited by 168position: middledoi
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
Open Forum Infectious Diseases 2021cited by 128position: middledoi
Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
The Lancet Regional Health - Western Pacific 2021cited by 24position: middledoi
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
EBioMedicine 2021cited by 20position: middledoi
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
The Lancet 2020cited by 491position: middledoi
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
Clinical Infectious Diseases 2020cited by 229position: middledoi
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
Nature Communications 2020cited by 196position: middledoi
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
EBioMedicine 2020cited by 166position: middledoi
The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study
European Heart Journal - Cardiovascular Pharmacotherapy 2020cited by 80position: middledoi
Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19
Open Forum Infectious Diseases 2020cited by 38position: middledoi
Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity
Frontiers in Immunology 2020cited by 31position: middledoi
Fingolimod treatment abrogates chikungunya virus–induced arthralgia
Science Translational Medicine 2017cited by 77position: middledoi
Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology
Journal of Virology 2015cited by 122position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lisa F. P. Ng · Agency for Science, Technology and Research10 papers (2015–2024)Laurent Rénia · Hospital Universitario de Gran Canaria Doctor Negrín9 papers (2015–2024)Siew‐Wai Fong · Agency for Science, Technology and Research7 papers (2020–2024)Barnaby Edward Young · National Centre for Infectious Diseases6 papers (2020–2021)David Chien Lye · Agency for Science, Technology and Research6 papers (2020–2021)Siti Naqiah Amrun · Agency for Science, Technology and Research5 papers (2017–2024)Seow Yen Tan · SingHealth4 papers (2020–2021)Yee‐Sin Leo · National University of Singapore4 papers (2020–2021) · 4 papers (2020–2024)Guillaume Carissimo · National University of Singapore4 papers (2020–2024)Bernett Lee · Nanyang Technological University3 papers (2020–2021)Paul Anantharajah Tambyah · National University of Singapore3 papers (2020–2021)Teck‐Hui Teo · National University of Singapore3 papers (2015–2024)Surinder Pada · Ng Teng Fong General Hospital3 papers (2020–2021)Fok‐Moon Lum · National University of Singapore3 papers (2015–2024)Sean Wei Xiang Ong · Institute for Work & Health2 papers (2021–2021) · 2 papers (2020–2020)Mark Chen · Cleveland Clinic2 papers (2020–2021)Jenny G. Low · Duke-NUS Medical School2 papers (2020–2021)Jean‐Laurent Casanova · Tehran University of Medical Sciences2 papers (2023–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Public Health, Environmental and Occupational Health →